Skip to content
Sulconazole
Exelderm (sulconazole) is a small molecule pharmaceutical. Sulconazole was first approved as Exelderm on 1985-08-30. It is used to treat cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Exelderm
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulconazole nitrate
Tradename
Company
Number
Date
Products
EXELDERMJourney MedicalN-018737 RX1989-02-28
1 products, RLD, RS
EXELDERMJourney MedicalN-018738 RX1985-08-30
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
exeldermNew Drug Application2022-10-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
cutaneous candidiasis—D002179—
mycoses—D009181B35-B49
tinea pedisEFO_0007512D014008B35.3
tinea versicolorEFO_0007439D014010B36.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D01: Antifungals for dermatological use
— D01A: Antifungals for topical use
— D01AC: Imidazole and triazole derivatives, topical antifungals
— D01AC09: Sulconazole
HCPCS
No data
Clinical
Clinical Trials
31 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urinary tract infectionsD014552EFO_0003103N39.0—212—5
InfectionsD007239EFO_00005442—11—4
Respiratory tract infectionsD012141J06.9—1—2—3
PneumoniaD011014EFO_0003106J18———112
Wound infectionD014946———112
Intraabdominal infectionsD059413———2—2
CholelithiasisD002769EFO_0004799K80———2—2
GonorrheaD006069DOID_7551A54———1—1
Open fracturesD005597———1—1
Bacterial skin diseasesD017192———1—1
Show 4 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PyelonephritisD011704EFO_1001141N10-N16—11——2
Lung abscessD008169EFO_1001362J85.2——1—12
Ventilator-associated pneumoniaD053717EFO_1001865J95.851——1——1
Iatrogenic diseaseD007049——1——1
BacteremiaD016470EFO_0003033R78.81——1——1
Aspiration pneumoniaD011015EFO_1001399J69.0——1——1
Bacterial pneumoniaD018410EFO_1001272J15.9——1——1
ChorioamnionitisD002821O41.12—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cleft palateD002972Q35—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Jaw fracturesD0075721————1
Healthy volunteers/patients—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PeritonitisD010538EFO_0008588K65————22
AppendicitisD001064EFO_0007149K37————11
CholecystitisD002764HP_0001082K81————11
Abdominal abscessD018784EFO_1001753————11
Risk factorsD012307EFO_0003919————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSULCONAZOLE
INNsulconazole
Description
1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole is a member of the class of imidazoles that is 1-ethyl-1H-imidazole in which one of the hydrogens of the methyl group is replaced by a (4-chlorobenzyl)sulfanediyl group while a second is replaced by a 2,4-dichlorophenyl group. It is a member of imidazoles, an organic sulfide, a dichlorobenzene and a member of monochlorobenzenes.
Classification
Small molecule
Drug classsystemic antifungals (miconazole type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
Identifiers
PDB—
CAS-ID61318-90-9
RxCUI37319
ChEMBL IDCHEMBL1221
ChEBI ID77776
PubChem CID5318
DrugBankDB06820
UNII ID5D9HAA5Q5S (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Exelderm - Fortress Biotech, Inc.
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Exelderm - Journey Medical
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 252 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3,478 adverse events reported
View more details